MedPath
TGA Approval

AUBAGIO (440030)

440030

AUBAGIO

Sanofi-Aventis Australia Pty Ltd

February 6, 2024

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

teriflunomide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AUBAGIO (440030) - TGA 批准文号 | MedPath